NB-355: a novel prodrug for L-DOPA with reduced risk for peak-dose dyskinesias in MPTP-treated squirrel monkeys. by Tye, S, Rupniak, N, Naruse, T, Miyaji, M, Iversen, S

Therapeutic effect of bortezomib for primary plasma cell leukemia followed by auto/allo stem cell transplantation by Ozasa R, Hotta M, Yoshimura H, Nakanishi T, Tamaki T, Fujita S, Nakamichi N, Miyaji M, Ishii K, Ito T, Nomura S

Get full text

Clinical features of late-onset circulatory dysfunction in premature infants by Koyama N, Kouwaki M, Tanaka T, Ohki S, Iwase K, Terasawa S, Miyaji M, Iwaki T, Kokubo M, Kobayashi S, Mizuno H, Fujimoto S, Togari H

Get full text